Literature DB >> 2868089

Intrinsic beta-sympathomimetic activity of dilevalol, R, R-isomer of labetalol.

K Matsunaga, K Nakamura, M Ueda.   

Abstract

The potency and selectivity of the intrinsic beta-sympathomimetic activity (ISA) of dilevalol were studied with isolated guinea-pig trachea and pithed rat. This drug relaxed the contracture of isolated guinea-pig tracheal preparation induced by histamine in a dose-dependent manner. The dose-response curves of dilevalol and labetalol were shifted to the right with propranolol pretreatment. The relaxing potency of dilevalol was approximately 4.7 times more potent than that of labetalol. Dilevalol markedly reduced the diastolic blood pressure with only a slight increase of heart rate in pithed rats, while isoproterenol and pindolol caused moderate to marked positive chronotropic effects in proportion to their hypotensive effects. These results suggest that dilevalol has more potent ISA than labetalol and shows more beta 2-adrenoceptor selectivity than pindolol.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2868089     DOI: 10.1248/bpb1978.8.785

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  7 in total

Review 1.  Progress in antihypertensive therapy with a multiple-action drug.

Authors:  B N Prichard; B Tomlinson
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  The effects of a single dose of dilevalol on [3H]-noradrenaline plasma kinetics and plasma lipoprotein cholesterol concentrations.

Authors:  L G Howes; P R Rowe; H Krum; W J Louis
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

Review 3.  Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.

Authors:  P Lund-Johansen; P Omvik
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

4.  A comparison of dilevalol and placebo in the management of isolated systolic hypertension using ambulatory monitoring.

Authors:  C A Silagy; J J McNeil; S Farish; B P McGrath
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

Review 5.  Dilevalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension.

Authors:  P Chrisp; K L Goa
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

6.  Comparison of the effects of dilevalol and propranolol on systemic and regional haemodynamics in healthy volunteers at rest and during exercise.

Authors:  E Bellissant; D Annane; C Thuillez; J F Giudicelli
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 7.  Adverse reactions with beta-adrenoceptor blocking drugs. An update.

Authors:  R V Lewis; C Lofthouse
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.